Research Report
Copyright ©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Apr 14, 2014; 20(14): 4059-4065
Published online Apr 14, 2014. doi: 10.3748/wjg.v20.i14.4059
Table 1 Baseline characteristics of patients
CharacteristicsLLS (n = 66)RFA (n = 67)P value
Gender-male48 (72.7)52 (77.6)0.514
Age (yr)55 (27-76)59 (39-85)0.002
BMI23.5 (17.8-33.4)23.6 (18.5-32.0)0.374
Etiology0.014
HBV51 (78.5)44 (65.7)
HCV4 (6.2)17 (25.4)
Alcoholic2 (3.1)2 (3.0)
NBNC4 (6.2)4 (6.0)
Others4 (6.2)0 (0)
WBC (/μL)5345 (2600-8950)4000 (2000-11000)0.007
Hemoglobin (g/dL)14.2 (10.8-17.7)14.0 (8.0-17.0)0.001
Platelet (/μL)149500 (51000-276000)103000 (50000-257000)0.000
INR1.1 (0.9-1.3)1.00 (1.0-2.0)0.000
Albumin (g/dL)4.3 (3.5-4.9)4.0 (3.0-5.0)0.000
Total bilirubin (mg/dL)0.7 (0.2-1.7)1.0 (0.2-2.0)0.538
AST (IU/L)33 (16-95)38 (12-124)0.007
ALT (IU/L)30 (10-162)35 (8-138)0.477
ALP (IU/L)78 (35-176)83 (45-189)0.392
Creatinine (mg/dL)0.91 (0.50-1.27)0.88 (0.46-2.64)0.507
ICG-R1510.5% (2.3%-24.9%)16.8% (3.3%-45.2%)0.000
AFP (ng/mL)28.5 (1-7102)20.0 (2-5652)0.323
PIVKA-II (mAU/mL)25 (3-500)18 (9-500)0.011
Tumor size (cm)2.1 (0.8-3.0)1.8 (1.0-2.9)0.035
Table 2 Risk factors for hepatocellular carcinoma recurrence by univariate analysis
Risk factorsOR95%CIP value
Group-RFA1.9341.141-3.2770.014
Gender-female0.5360.264-1.0900.085
Age1.0150.991-1.0400.217
BMI1.0660.972-1.1690.177
WBC0.9240.781-1.0930.354
Hemoglobin0.9000.773-1.0470.171
Platelet0.9930.988-0.9980.008
INR0.7300.019-27.6730.865
Albumin0.4070.255-0.6500.000
Total bilirubin0.9700.539-1.7460.920
AST1.0080.996-1.0190.196
ALT1.0020.992-1.0110.736
ALP1.0010.993-1.0090.816
Creatinine1.5110.490-4.6550.473
ICG-R151.0481.015-1.0820.004
AFP1.0001.000-1.0000.980
PIVKA-II1.0041.001-1.0070.017
Tumor size0.9520.907-1.0000.050